R, L., A, M., CT, F., D, D., L, G., RS, S., & AS, K. (2025). Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants. British journal of clinical pharmacology, 91(7), 2070. https://doi.org/10.1002/bcp.70020
Chicago Style (17th ed.) CitationR, Luo, Madan A, Ferrara-Cook CT, Dalvie D, Goulet L, Struthers RS, and Krasner AS. "Oral Paltusotine, a Nonpeptide Selective Somatostatin Receptor 2 Agonist: Mass Balance, Absolute Bioavailability and Metabolism in Healthy Participants." British Journal of Clinical Pharmacology 91, no. 7 (2025): 2070. https://doi.org/10.1002/bcp.70020.
MLA (9th ed.) CitationR, Luo, et al. "Oral Paltusotine, a Nonpeptide Selective Somatostatin Receptor 2 Agonist: Mass Balance, Absolute Bioavailability and Metabolism in Healthy Participants." British Journal of Clinical Pharmacology, vol. 91, no. 7, 2025, p. 2070, https://doi.org/10.1002/bcp.70020.